Zacks: Analysts Expect U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $106.49 Million

Wall Street analysts expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will post sales of $106.49 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for U.S. Physical Therapy’s earnings, with the highest sales estimate coming in at $110.91 million and the lowest estimate coming in at $102.07 million. U.S. Physical Therapy posted sales of $90.86 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 17.2%. The firm is expected to report its next earnings report on Wednesday, June 6th.

On average, analysts expect that U.S. Physical Therapy will report full year sales of $106.49 million for the current year, with estimates ranging from $406.92 million to $415.75 million. For the next fiscal year, analysts forecast that the company will report sales of $451.17 million per share, with estimates ranging from $440.26 million to $462.09 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). U.S. Physical Therapy had a net margin of 6.40% and a return on equity of 10.51%. The firm had revenue of $103.03 million for the quarter, compared to the consensus estimate of $102.69 million.

Several analysts have commented on USPH shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $74.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 2nd. Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research report on Tuesday, August 29th. Sidoti raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $62.00 to $74.00 in a research report on Friday, September 8th. BidaskClub raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. Finally, Barrington Research lowered shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $69.00.

Shares of U.S. Physical Therapy (NYSE:USPH) opened at $71.95 on Friday. The company has a market cap of $919.05, a PE ratio of 35.29, a price-to-earnings-growth ratio of 3.14 and a beta of 1.08. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.04 and a quick ratio of 2.04. U.S. Physical Therapy has a 12-month low of $56.50 and a 12-month high of $78.00.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Shareholders of record on Friday, November 17th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.11%. The ex-dividend date is Thursday, November 16th. U.S. Physical Therapy’s dividend payout ratio is 48.19%.

In other news, CFO Lawrance W. Mcafee sold 800 shares of U.S. Physical Therapy stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $69.21, for a total value of $55,368.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Christopher J. Reading sold 15,000 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $66.52, for a total transaction of $997,800.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 23,000 shares of company stock worth $1,535,652. Insiders own 3.10% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Pinebridge Investments L.P. increased its stake in shares of U.S. Physical Therapy by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after purchasing an additional 17 shares in the last quarter. Texas Permanent School Fund increased its stake in shares of U.S. Physical Therapy by 0.8% in the second quarter. Texas Permanent School Fund now owns 9,142 shares of the company’s stock worth $552,000 after purchasing an additional 76 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of U.S. Physical Therapy by 3.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after purchasing an additional 90 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of U.S. Physical Therapy by 3.0% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 6,868 shares of the company’s stock worth $415,000 after purchasing an additional 200 shares in the last quarter. Finally, Thrivent Financial For Lutherans increased its stake in shares of U.S. Physical Therapy by 5.9% in the second quarter. Thrivent Financial For Lutherans now owns 7,570 shares of the company’s stock worth $457,000 after purchasing an additional 420 shares in the last quarter. Hedge funds and other institutional investors own 99.65% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Zacks: Analysts Expect U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $106.49 Million” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/03/zacks-analysts-expect-u-s-physical-therapy-inc-usph-will-announce-quarterly-sales-of-106-49-million.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply